Imaging features and differentiation between benign and malignant Brenner tumors in a multi-center cohort - Scorecard - MDSpire

Imaging features and differentiation between benign and malignant Brenner tumors in a multi-center cohort

  • By

  • Tao Zhou

  • Peng Xia

  • Qinghai Miao

  • Li Li

  • Libin Cao

  • Zhongqiu Wang

  • Zefeng Shao

  • Na Duan

  • June 12, 2026

  • 0 min

Share

Clinical Scorecard: Imaging Characteristics and Distinction of Benign versus Malignant Brenner Tumors in a Multi-Center Study

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with pathologically confirmed ovarian Brenner tumors.
Care Setting

Key Highlights

  • Study analyzed clinical and imaging data from 52 patients diagnosed with BTs, addressing a gap in existing literature.

Guideline-Based Recommendations

Diagnosis

  • Utilize imaging features such as tumor diameter, composition, and enhancement for differential diagnosis, including CT and MRI.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Management strategies for borderline and malignant forms should be specified.

        Clinical Best Practices

        • Incorporate imaging characteristics in preoperative assessments.
        • Utilize a multi-disciplinary approach for diagnosis and management.
        • Regularly assess tumor markers in patients with suspected BTs.
        • Recommend follow-up imaging protocols.

        Related Resources & Content

        Original Source(s)

        Related Content